Kelley D S, Bartolini G L, Warren J M, Simon V A, Mackey B E, Erickson K L
Western Human Nutrition Research Center, ARS, USDA, Department of Nutrition, University of California, Davis, California 95616, USA.
Lipids. 2004 Feb;39(2):135-41. doi: 10.1007/s11745-004-1211-9.
The purpose of this study was to examine the effects of two purified isomers of CLA (c9,t11-CLA and t10,c12-CLA) on the weights and FA compositions of hepatic TG, phospholipids, cholesterol esters, and FFA. Eight-week-old female mice (n = 6/group) were fed either a control diet or diets supplemented with 0.5% c9,t11-CLA or t10,c12-CLA isomers for 8 wk. Weights of liver total lipids and those of individual lipid fractions did not differ between the control and the c9,t11-CLA groups. Livers from animals fed the t10, c12-CLA diet contained four times more lipids than those of the control group; this was mainly due to an increase in the TG fractions (fivefold), but cholesterol (threefold), cholesterol esters (threefold), and FFA (twofold) were also significantly increased. Although c9,t11-CLA did not significantly alter the weights of liver lipids when compared with the control group, its intake was associated with significant reductions in the weight percentage (wt% of total FAME) of 18:1n-9 and 18:1n-7 in the TG fraction and with significant increases in the weight percentage of 18:2n-6 in the TG, cholesterol ester, and phospholipid fractions. On the other hand, t10,c12-CLA intake was linked with a significant increase in the weight percentage of 18:1n-9 and a decrease in that of 18:2n-6 in all lipid fractions. These changes may be the result of alterations in the activity of delta9-desaturase (stearoyl CoA desaturase) and the enzymes involved in the metabolism of 18:2n-6. Thus, the two isomers differed not only in their effects on the weights of total liver lipids and lipid fractions but also on the FA profile of the lipid fractions.
本研究的目的是检测共轭亚油酸(CLA)的两种纯化异构体(c9,t11-CLA和t10,c12-CLA)对肝脏甘油三酯(TG)、磷脂、胆固醇酯和游离脂肪酸(FFA)的重量及脂肪酸(FA)组成的影响。8周龄雌性小鼠(每组n = 6)被喂食对照饮食或添加0.5% c9,t11-CLA或t10,c12-CLA异构体的饮食,持续8周。对照和c9,t11-CLA组之间肝脏总脂质及各个脂质组分的重量没有差异。喂食t10,c12-CLA饮食的动物肝脏脂质含量是对照组的四倍;这主要是由于TG组分增加(五倍),但胆固醇(三倍)、胆固醇酯(三倍)和FFA(两倍)也显著增加。尽管与对照组相比,c9,t11-CLA没有显著改变肝脏脂质的重量,但其摄入与TG组分中18:1n-9和18:1n-7的重量百分比(占总脂肪酸甲酯的wt%)显著降低以及TG、胆固醇酯和磷脂组分中18:2n-6的重量百分比显著增加有关。另一方面,t10,c12-CLA的摄入与所有脂质组分中18:1n-9的重量百分比显著增加以及18:2n-6的重量百分比降低有关。这些变化可能是δ9-去饱和酶(硬脂酰辅酶A去饱和酶)及参与18:2n-6代谢的酶活性改变的结果。因此,这两种异构体不仅对肝脏总脂质和脂质组分的重量影响不同,而且对脂质组分的FA谱也有不同影响。